WuXi Biologics (02269.HK) purchased approximately 160.50 million shares for about 49.84 million Hong Kong dollars on June 23.

The financial news app of Citic Securities announced that WuXi Biologics (02269.HK) issued a statement on June 23, 2026 that the company will spend approximately 49.8406 million Hong Kong dollars to repurchase 1.605 million shares at a repurchase price of HK$30.62 to HK$31.34 per share.